Bank of America’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Bank of America's IDXX Position: Q2 2026 in Review
Bank of America reduced its Idexx Laboratories (IDXX) stake by 2.3% in Q2 2026, selling an estimated $6.18M and leaving 476,998 shares worth $251M. The position accounts for 0.02% of the portfolio, ranked #682.
Bank of America first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $799M in Q3 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Bank of America held 476,998 shares of Idexx Laboratories worth $251M as of Q2 2026.
- Bank of America sold 11,019 Idexx Laboratories shares in Q2 2026, an estimated $6.18M.
- Idexx Laboratories made up 0.02% of Bank of America's portfolio in Q2 2026, its #682 holding.
- Bank of America first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Bank of America's Idexx Laboratories position peaked at $799M in Q3 2021.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.